According to a new quarterly revenue cycle benchmarking report from Kodiak Solutions, health insurers are increasingly using requests for additional information to initially deny claims from hospitals, health systems, and medical practices. This practice is leading to significant delays in…
Apyx Medical Corporation (NASDAQ: APYX), the maker of the Renuvion® helium plasma and radiofrequency platform, has announced a peer-reviewed article in Plastic and Reconstructive Surgery—Global Open. The study compares Renuvion’s Helium Plasma Technology with InMode’s Bipolar RF System following liposuction…
LEAP Consulting Group, a specialized digital consultancy for the clinical laboratory sector, is thrilled to introduce a new service designed to assist CLIA-certified labs in navigating the FDA’s updated requirements under the LDT Final Rule announced in May 2024. This…
Ontrak, Inc. (NASDAQ: OTRK), a leader in AI-powered and technology-driven behavioral healthcare, today released its expected financial results for the second quarter ending June 30, 2024. These results are pending final analysis of debt classification by management. Management Commentary Brandon…
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company specializing in novel small molecule therapies from its boron chemistry platform, today announced topline results from the Phase 2 portion of the EBO-301 Phase 2/3 study. This study evaluates the efficacy of…
Phonak, a Sonova brand, is excited to introduce the new Infinio hearing aid portfolio, featuring the groundbreaking Audéo Sphere Infinio. This hearing aid is the world’s first to use a dedicated real-time AI chip specifically designed for speech-from-noise separation. Addressing…
Hims & Hers Health, Inc. (NYSE: HIMS), a leading health and wellness platform, has released its financial results for the second quarter ended June 30, 2024. The details are available in the shareholder letter posted at investors.hims.com. Hims & Hers…
Concentric Analgesics, Inc., a clinical-stage biopharmaceutical firm specializing in innovative non-opioid pain treatments, has unveiled new positive clinical data for vocacapsaicin, its leading product candidate for managing postsurgical pain. The data will be presented in a poster session at the…
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotech firm focused on developing small molecule drugs for virology and immunology, has reported its financial results for the fiscal third quarter ending June 30, 2024. Recent Business Highlights: Clinical and Research Updates: Upcoming…
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company specializing in treating primary and metastatic liver cancers, has announced its financial results and business highlights for the second quarter ended June 30, 2024. Recent Business Highlights “We are thrilled with…
California University of Science and Medicine (CUSM) has announced a grant from Bank of America to enhance healthcare in rural Inland Empire communities. The funding will support CUSM’s initiative to provide simulation-based clinical equipment and training to healthcare facilities and…
Tris Pharma, Inc., a biopharmaceutical company specializing in ADHD, pain, addiction, and neurological disorders, has announced new clinical data showcasing that cebranopadol, a dual nociceptin/orphanin FQ peptide (NOP) receptor and µ-opioid peptide (MOP) receptor agonist, causes significantly less respiratory depression…